Back to Search
Start Over
Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases.
Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases.
- Source :
- Journal of Medicinal Chemistry; Sep2010, Vol. 53 Issue 18, p6629-6639, 11p
- Publication Year :
- 2010
Details
- Language :
- English
- ISSN :
- 00222623
- Volume :
- 53
- Issue :
- 18
- Database :
- Supplemental Index
- Journal :
- Journal of Medicinal Chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 53750522
- Full Text :
- https://doi.org/10.1021/jm100540x